TrialClinical and vaccine immunology : CVI2015

Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.

Gerald Aichinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.